Urologists recommend AS more often than rad/oncs (but probably not enough)

A new article on the Medscape web site, based on an article by Kim et al. in the journal Medical Care, deals with urologists’ and radiation oncologists’ recommendations for active surveillance (AS) as an appropriate form of treatment for low-risk prostate cancer in the USA today. … READ MORE …

Lancet comments on PBRT in treatment of prostate cancer

On June 5 we had noted that, the day before, the American Society for Radiation Oncology (ASTRO) released its model policy on the use of proton beam radiation therapy (PBRT) and related reimbursement issues. … READ MORE …

To operate or not to operate (in young men diagnosed with TxN1M0 disease)

The appropriate treatment of younger, otherwise healthy men diagnosed with non-metastatic but lymph node-positive prostate cancer (perhaps 10 percent of all patients to be diagnosed with localized prostate cancer in America in 2014) is controversial. … READ MORE …

Recovery of urinary continence, erectile function post-surgery

An article in Urology from the health outcomes group at Memorial Sloan-Kettering Cancer Center (MSKCC) has now given us greater insight into the potential for recovery of urinary continence and erectile function post-radical prostatectomy. … READ MORE …

Dr. Ian Thompson on the Cure Panel Talk Show

On Thursday this week, at 5:00 pm Eastern (2 p.m. Pacific), the Cure Panel Talk show will feature Dr. Ian Thompson, co-chair of the Genitourinary Cancers section for the Southwest Oncology Group, on the topic of important clinical trials for prostate cancer. … READ MORE …

Genetic screening for cancer … a case study from the NEJM

Many of our readers might be interested in looking at a hypothetical case study about the value of genetic screening for cancer risk for an asymptomatic, 45-year-old male patient who has a family history including three members diagnosed with cancer (one of whom was diagnosed with prostate cancer). … READ MORE …

“Cura te ipsum” or “First, heal thyself”

Interestingly, in contradistinction to the study by Randdazzo et al. just reported, come data on the personal attitudes and feelings of (some) American urologists about PSA screening and prostate cancer treatment — as applied to themselves. … READ MORE …

The value of focal therapy in the treatment of localized prostate cancer

The appropriate use of focal therapy in the treatment of low-risk and perhaps intermediate-risk prostate cancer is a very controversial topic (despite the heavy promotion of this type of treatment by a relatively small number of clinicians). … READ MORE …

Bill Manning’s blog: Part IV

Here is the fourth of Bill’s blog posts. He, and we, hope it will be helpful to all those battling late stage prostate cancer as he takes advantage of some of the new drugs that have come to market over the past couple of years. Click here for earlier parts if you missed them. … READ MORE …

What’s in the June 2014 issue of AUA News?

This issue of the AUA News contains three very different articles that may be of interest to at least some of our readers: … READ MORE …

Florida-based urologist suspended and fined

According to a report in The Tampa Bay Times this morning, the Florida Board of Medicine has imposed a one-year suspension and a significant fine on a relatively well-known urologist who has been diagnosing prostate cancer exclusively on the basis of magnetic resonance imaging (MRIs), without a confirmatory biopsy. … READ MORE …

Can biomarkers in semen accurately detect prostate cancer risk?

According to a research letter accepted for publication in the journal Endocrine-Related Cancer, a group of Australian researchers are suggesting that prostate cancer-specific biomarkers may be identifiable in male semen. … READ MORE …

Upcoming educational teleconference on exercise and cancer therapy

The people at the Cure Panel Talk Show are putting together a first audio teleconference on “Exercising with Cancer, Why and How It Helps” on June 19 at 6 p.m. Eastern time. This may be of interest to a number of readers of this blog. The lead speaker will be Dr. Donald Abrams of the UCSF Osher Center for Integrative Medicine.

What happened at the ASCO meeting yesterday?

Friday was a very quiet day from a prostate cancer perspective, and there was really nothing significant to report.

The ASCO session on the costs of care that we have mentioned previously was relatively “benign”, in that the various speakers “laid out their views of the land” and acknowledged the need for change. However, finding common ground is going to be a real challenge for all concerned unless we can all agree on some very basic principles.

Is getting your LHRH shots a painful experience for you?

If getting your 3-, 4-, or 6-monthly injections of an LHRH agonist like Lupron or Eligard is a painful experience (and you haven’t heard about this before), you might like to ask about icing the skin at the injection site prior to getting the injection. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,112 other followers